Professional Documents
Culture Documents
Payward Drug Study and Fdar
Payward Drug Study and Fdar
NBC2
DRUG STUDY
DRUG ACTION
Interferes with Moderate to CNS: headache, Patient monitoring:
Brand Name: binding to cell of skin, bone, GI: nausea, vomiting, adverse effects, including
Metabolic: hyperglycemia
multiforme, Stevens-
syndrome
anaphylaxis with
food every 12 hours as prescribed.
signs
away.
changes.
F- Anxiety
D-States he does not want to sit with or talk to other; they frighten him; stay in room alone unless
strongly encouraged to come out; no group involvement; at times listens to group conversation from a
distance, but does not interact; some hypervigilance and scanning noted.
A-Encourage patient to share thoughts and feelings, promote calm quiet environment, encourage and
foster patient’s interaction with support systems.
R-Cooperative with therapy; still acts uncomfortable in the presence of the group of people; accepted
positive feedback from nurse.
D- Received patient awake lying on bed, conversant, oriented t her surroundings, with signs of
distress at this moment, pain in her lower abdomen with a pain scale of 8/10, she was not able to walk
by herself since she was admitted in the hospital.
A- Vital signs checked and taken, discuss treatment alternatives, administer pain medication as
prescribed, demonstrated/ encourage use of relaxation activities, review dietary restriction refer to
local support group so that she can interact with cancer survivors.
R- Recipient to the given health teaching. Pain scale drop to 6/10 from 8/10
REFERENCES:
https://nurseslabs.com/anxiety/
https://www.drugs.com/ferrous_sulfate.html
https://www.drugs.com/ondansetron.html
https://www.drugs.com/ranitidine.html
https://www.rxlist.com/consumer_hydrocortisone/drugs-condition.htm
https://www.webmd.com/drugs/2/drug-18423/cefuroxime-sodium-intravenous/details